Clinical Trial Update: Diffuse Fibrotic Lung Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial addressing diffuse fibrotic lung disease has completed its study (status: COMPLETED). The update lists related conditions including pulmo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis
• Sarcoidosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Pulmonary Fibrosis | Phase 2 | Status: COMPLETED